GB PHARMA ApS: Financial statements 2019
CVR: 36054220
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
GB PHARMA ApS (CVR 36054220) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 46,665 and a net result of DKK 24,575 compared with DKK 41,349 the year before. That is an increase of 8.6% compared with the year before. The profit margin was 52.7%. Equity in the 2019 report amounted to DKK -1,920,789.
- Revenue
- DKK 46,665
- Gross Profit
- DKK 18,992
- Profit/Loss
- DKK 24,575
- Equity
- DKK -1,920,789
- Total Assets
- DKK 43,758
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 47 t. | 19 t. | 25 t. | -1.9 mio. | 0 |
| 2018 | 43 t. | 23 t. | 41 t. | -1.9 mio. | 0 |
| 2017 | - | 9 t. | 50 t. | -2 mio. | 0 |
| 2016 | - | -426 t. | -664 t. | -2.7 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
GB PHARMA ApS has published its annual report for 2018. Revenue came to DKK 42,975, and the net result was DKK 41,349.
About GB PHARMA ApS
GB PHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2014. The company is registered under the industry Detailhandel med kosmetikvarer og toiletartikler. The management consists of Gunnar Kjems. The board consists of Gunnar Kjems (chair). The company is owned by Gunnar Kjems. The company has 0 employees (2016). In 2025, the company reported a gross profit of DKK -10,000 and a net result of DKK 31,613 compared with DKK -4,949 the year before. Equity in the 2025 report amounted to DKK -1,902,842.